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ABSTRACT
CONTEXT AND OBJECTIVE: Occurrences of liver failure following jejunoileal bypass were extensively re-
ported in the past and were one of the main factors that led to abandonment of this procedure. The newer 
predominantly malabsorptive procedures called biliopancreatic diversions (BPDs) have also been impli-
cated in several cases of acute and subacute liver failure. The aim here was to review the current available 
evidence on occurrences of liver failure following BPDs. 
DESIGN AND SETTING: Narrative review; bariatric surgery service of a public university hospital.
METHODS: A review of the literature was conducted through an online search of medical databases.
RESULTS: Associations between BPDs and liver failure have only infrequently been reported in the lit-
erature. However, they appear to be more than merely anecdotal. The pathophysiological mechanisms 
remain obscure, but they seem to be related to rapid weight loss, protein malnutrition, deficits of hepato-
trophic factors, high circulating levels of free fatty acids and bacterial overgrowth in the bypassed bowel 
segments. Reversal of the BPD may ameliorate the liver impairment.
CONCLUSIONS: Although infrequent, liver failure remains a concern following BPDs. Careful follow-up is 
required in individuals who undergo any BPD.
RESUMO
CONTEXTO E OBJETIVO: A ocorrência de falência hepática após a derivação jejunoileal foi extensiva-
mente descrita no passado e foi um dos principais fatores que levaram ao abandono do procedimento. 
Os  procedimentos predominantemente malabsortivos mais modernos, chamados de derivações bilio-
pancreáticas, também já foram implicados em diversos casos de falência hepática aguda e subaguda. 
O objetivo foi revisar a atual evidência disponível sobre a ocorrência de insuficiência hepática após deri-
vações biliopancreáticas.
TIPO DE ESTUDO E LOCAL: Revisão narrativa; Serviço de Cirurgia Bariátrica de hospital universitário.
MÉTODOS: Revisão da literatura conduzida por meio de pesquisa online de bancos de dados médicos.
RESULTADOS: A associação entre derivações biliopancreáticas e falência hepática na literatura é infre-
quente. Entretanto, ela aparenta ser mais do que meramente anedótica. Os mecanismos fisiopatológicos 
continuam pouco compreendidos, mas parecem estar relacionados à rápida perda de peso, desnutrição 
proteica e déficit de fatores hepatotróficos, altos níveis circulantes de ácidos graxos livres e supercresci-
mento bacteriano em segmentos intestinais excluídos do trânsito. A reversão da cirurgia pode melhorar 
o comprometimento hepático.
CONCLUSÕES: Embora infrequente, a falência hepática continua sendo preocupante após as derivações 
biliopancreáticas. Seguimento cuidadoso é mandatório em indivíduos submetidos a essas cirurgias.
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INTRODUCTION
Obesity has become a worldwide public health concern over recent 
decades. In 2014, according to the World Health Organization 
(WHO), more than 1.9 billion adults were at least overweight; of 
these, over 600 million were obese.1 Recent reports have observed 
that the prevalence of obesity in Brazil is 17.9%, which corre-
sponds to almost thirty million obese people.2 Bariatric surgery 
has become the standard treatment for refractory morbid obesity 
nowadays. Brazil is currently the country with the second largest 
number of bariatric surgery procedures performed every year, only 
behind the United States.3
The first bariatric procedures, which were described as early as 
in the 1950s, were jejunocolic and jejunoileal bypasses. Jejunoileal 
bypass was characterized as a bypass from the proximal jejunum to 
the distal ileum, with exclusion of the majority of the small bowel 
of the digestive tract. Despite its popularity from the 1950s to the 
1970s, it was abandoned especially because of high rates of severe 
protein-calorie malnutrition and acute and subacute liver failure 
related to the procedure. However, the newer predominantly mal-
absorptive procedures called biliopancreatic diversions (BPDs) 
have also been implicated in several cases of acute and subacute 
liver failure.4
BPD mainly encompasses two different bariatric procedures: 
the Scopinaro operation and the duodenal switch procedure. 
The Scopinaro operation basically involves distal gastrectomy with 
a bypass from the remnant stomach to the distal ileum. The duo-
denal switch consists of resection of the gastric greater curvature 
and distal bypass from the duodenum to the ileum. The duodenal 
switch procedure is a modification of the original BPD and uses 
a longer common channel than the classic BPD. It was designed 
to improve gastric emptying and to decrease postoperative diar-
rhea and anastomotic ulceration. Both procedures are associated 
with high rates of resolution of type 2 diabetes. However, they 
are also associated with occurrences of protein-calorie malnutri-
tion. Hence, although they are still performed today, they are not 
routinely the operations of choice in most centers.5 In the 2003 
IFSO report, the Scopinaro operation accounted for 2% and duo-
denal switch for 2.8%.6 In the latest report (in 2013) from the 
International Federation of Surgery of Obesity and Metabolic 
Disorders (IFSO), duodenal switch accounted for about 1.5% of 
all bariatric procedures performed throughout the world, while 
the statistics for the Scopinaro operation did not appear, since it 
accounted for less than 1%.7 
Regarding liver disease, BPDs are usually linked to major 
improvements in metabolic abnormalities relating to nonalcoholic 
fatty liver disease (NAFLD), especially insulin resistance, but at the 
same time, there has been a steady rate of occurrence of reports 
of acute and subacute liver failure following BPDs over the years.
OBJECTIVES
This study aimed to review the current available evidence on 
occurrences of liver failure following biliopancreatic diversions.
METHODS
A review of the literature was conducted through an online 
search for the MeSH terms “liver failure”, “biliopancreatic diver-
sion” and “bariatric surgery” in Medline (via PubMed); and the 
MeSH/DeCS terms “liver failure”, “biliopancreatic diversion” and 
“bariatric surgery” in Lilacs (via Bireme) (Table 1).
After extensive online research, we identified three case reports 
and two case series on liver failure subsequent to the classical 
Scopinaro operation; and one case report and one case series of liver 
failure subsequent to the duodenal switch procedure. Additionally, 
we also researched population studies that addressed the evolution 
of liver disease after biliopancreatic diversions and identified two 
large cohort studies (one retrospective and other prospective) on 
liver impairment subsequent to the classical Scopinaro operation; 
and two retrospective cohorts on liver impairment subsequent to 
duodenal switch. We also excluded two case reports on liver fail-
ure after jejunoileal bypass: one case report on liver failure after 
biliointestinal bypass and one case series on liver failure after con-
version of classical gastric bypass to distal bypass.
RESULTS
Scopinaro operation
The reports on liver failure requiring liver transplantation or 
leading to death following the Scopinaro operation are more than 
anecdotal. Although the rate of occurrence of liver failure appears 
to be non-significant in large cohort studies, there is enough evi-
dence to consider that these occurrences in individuals who 
underwent this procedure are more than mere coincidence.8
Table 1. Database search results for liver failure following biliopancreatic diversions, on May 22, 2016 
Electronic databases Search strategies Results
MEDLINE (PubMed) (Liver failure) AND (Biliopancreatic Diversion) AND (Bariatric surgery)
3 case series
4 case reports
LILACS (Bireme)
((Liver failure) OR (Fallo hepático) OR (Falência Hepática)) AND ((Biliopancreatic Diversion) OR 
(Desviación Biliopancreática) OR (Desvio biliopancreático) AND ((Bariatric surgery) OR (Cirurgia 
Bariátrica) OR (Cirurgia bariátrica))
2 case series
3 case reports
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Grimm et al.9 reported the first case of chronic end-stage cir-
rhosis after BPD in 1992. The first successful liver transplantation 
to treat this complication was reported by Castillo et al. in 2001.10 
Greco et al.11 reported the case of an individual who developed 
liver failure 16 years after undergoing the Scopinaro operation 
and presented partial recovery of liver function after the primary 
procedure had been dismantled. D’Albuquerque et al.12 reported 
on three cases of liver failure that occurred between seven and 
24 months after the Scopinaro operation: two of the patients under-
went liver transplantation and one died. In a survey on liver trans-
plantation centers in Belgium, Geerts et al.8 detected 10 cases of 
bariatric surgery-related liver failure, of which nine were caused 
by the Scopinaro operation and one by jejunoileal bypass; the 
median time taken to develop liver failure was five years. All of 
these authors emphasized that, along with transplantation, the 
intestinal bypass must be revised and the original procedure must 
be dismantled.8,10,11 Table 2 summarizes the main articles on liver 
failure subsequent to the Scopinaro operation.
Despite the reports of liver failure, large population studies have 
not identified a significant frequency of occurrence of this compli-
cation. Scopinaro et al. conducted a classical retrospective analysis 
on 2,241 individuals who underwent their procedure and did not 
identify a single case of liver failure.15 Papadia et al. did not find 
any cases of liver failure in a prospective study that enrolled 99 con-
secutive subjects who underwent the same procedure. However, 
they observed significant early transient hepatocellular necrosis 
following the procedure, and noted that individuals with abnor-
malities seen previously through liver histological analysis were 
more likely to present postoperative acute liver damage.16 Table 3 
summarizes the main findings from these population studies.
Duodenal switch
Although the duodenal switch procedure has been more fre-
quently performed than the Scopinaro operation, at least since 
the 2000s,6 liver failure appears to be less frequent with this tech-
nique than with the classical Scopinaro operation. However, 
some cases have been reported. Auclair et al.13 reported the first 
case of liver failure following duodenal switch, which underwent 
successful liver transplantation. Baltasar17 and Baltasar et  al.18 
reported on two cases of liver failure following duodenal switch, 
of whom one underwent transplantation and the other died 
while on the waiting list. Table 4 summarizes the main articles 
on liver failure subsequent to duodenal switch.
The exact mechanisms that lead to liver failure following 
BPD and its current prevalence remain uncertain. Baltasar et al.18 
observed, in a large population study that enrolled 470 individuals 
Table 2. Articles on liver failure subsequent to the Scopinaro operation
Author n Treatment Outcome
Grimm et al.9 1 Supportive therapy Death
Castillo et al.10 1 Liver transplantation Successful
Greco et al.11 1 Reversal of intestinal bypass Successful
D’Albuquerque 
et al.12
3
2: Liver transplantation
1: Supportive therapy
2: Successful (liver transplantation)
1: Death awaiting a graft
Geerts et al.8
10 (9: BPD; 
1: jejunoileal 
bypass)
7: Liver transplantation
2: Supportive therapy
1: Awaiting transplantation
4: Successful
1: Successful transplantation followed by death due to “de novo” cancer 6 years later
2: Death after transplantation
1: Jejunoileal bypass – reappearance of liver failure 10 months after transplantation; 
required retransplantation
2: Death while awaiting graft
Table 3. Population-based studies evaluating liver impairment following Scopinaro operation and duodenal switch
Study Surgical technique n Study design Cases of liver failure - n (%)
Scopinaro et al.15 Scopinaro 2,241 Retrospective cohort 0
Papadia et al.16 Scopinaro 99 Prospective cohort 0
Baltasar et al.18 Duodenal switch 470 Retrospective cohort 1 (0.2%)
Keshishian et al.19 Duodenal switch 697 Retrospective cohort 0
Author n Treatment Outcome
Auclair et al.13 1 Liver transplantation Successful
Baltasar17 2
1: Liver transplantation
1: Supportive therapy (while awaiting graft)
1: Liver transplantation – successful
1: Died while awaiting graft
Table 4. Articles on liver failure subsequent to duodenal switch
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who underwent duodenal switch, that only 10 (2.1%) of them devel-
oped liver impairment, ranging from asymptomatic liver enzyme 
abnormalities to fatal acute liver failure. Conversely, in a study that 
enrolled 697 individuals, Keshishian et al.19 found no evidence of 
liver impairment following duodenal switch. The main findings 
of these population-based studies are summarized in Table 3.
Pathophysiology
The pathophysiological pathways potentially enrolled in devel-
opment of liver failure following BPD appear to consist of early 
rapid weight loss, a degree of protein malnutrition, lack of hepa-
totrophic factors and the effect of high levels of mobilized circu-
lating free fatty acids.17-19 Exclusion of the long jejunoileal loop 
can lead to injury to the intestinal mucosal barrier due to nonuse 
or to functional exclusion of the alimentary bolus. The resulting 
impaired function of the mucosal barrier may facilitate absorp-
tion into the portal venous system of a variety of macromolecules, 
such as inflammatory cytokines and intestinal toxins arising as a 
result of changes to the intestinal bacterial flora. After delivery to 
the liver, these macromolecules may exacerbate hepatic injury.12 
Even in individuals who do not develop liver failure, BPDs 
seem to promote a bimodal effect in liver function tests, with 
early worsening of liver injury, followed by normalization and 
improvement.9,17 The reversal of some hepatic features following 
dismantling of the gut bypass emphasizes the role that this pro-
cedure plays in relation to the onset of liver failure. It is possible 
to propose that the procedure may trigger this change in indi-
viduals who are somewhat predisposed towards this. The predis-
position factors involved are yet to be identified. In any case, it is 
reasonable to consider that this surgery is unjustifiable for obese 
individuals who currently present signs of fibrosis, steatohepatitis 
and advanced liver disease. Moreover, all individuals undergoing 
BPD should be carefully followed up, at least by means of serial 
liver enzyme tests, not just in the early postoperative period, but 
for their entire lifetime.8
CONCLUSIONS
Although very rare, liver failure remains a concern following 
BPDs. However, since the vast majority of the evidence available 
is from case reports, there is no evidence level sufficient to pro-
vide definite conclusions. Randomized trials comparing the dif-
ferent available bariatric techniques are needed in order to pro-
vide data of better quality. Nonetheless, despite the low frequency 
of occurrences of liver failure, such events are reported nowhere 
near as often following other, more frequently performed bar-
iatric techniques. The exact mechanism that leads to this omi-
nous complication remains to be determined, but it seems to be 
characterized by an acute-on-chronic failure that occurs in pre-
disposed individuals who present previous liver impairment. 
Careful follow-up is required among individuals who undergo 
any BPD. Reversal of the procedure is warranted when early clin-
ical or laboratory signs of liver failure appear. Despite the lack 
of specific evidence, it is reasonable to avoid this surgical tech-
nique among subjects who present to bariatric surgeons with any 
degree of significant liver function impairment.
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